{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:02:33Z","timestamp":1786132953712,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1681\/asn.2014111109","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T22:12:05Z","timestamp":1431468725000},"page":"144-157","source":"Crossref","is-referenced-by-count":31,"title":["Podocyte p53 Limits the Severity of Experimental Alport Syndrome"],"prefix":"10.1681","volume":"27","author":[{"given":"Ryosuke","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Suico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Omachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Taura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20230208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-#","article-title":"The clinical spectrum of type IV collagen mutations.","volume":"9","author":"Lemmink","year":"1997","journal-title":"Hum Mutat"},{"key":"R2-19-20230208","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1681\/ASN.V9122291","article-title":"High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing.","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R3-19-20230208","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen.","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-19-20230208","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00467-011-1868-z","article-title":"Glomerular pathology in Alport syndrome: a molecular perspective.","volume":"27","author":"Cosgrove","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R5-19-20230208","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.ASN.0000102468.37809.C6","article-title":"Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis.","volume":"15","author":"Moeller","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R6-19-20230208","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/path.4046","article-title":"Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury.","volume":"228","author":"Ryu","year":"2012","journal-title":"J Pathol"},{"key":"R7-19-20230208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1083\/jcb.201009059","article-title":"p53 and its mutants in tumor cell migration and invasion.","volume":"192","author":"Muller","year":"2011","journal-title":"J Cell Biol"},{"key":"R8-19-20230208","doi-asserted-by":"crossref","first-page":"37503","DOI":"10.1074\/jbc.M110.136796","article-title":"AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.","volume":"285","author":"Eid","year":"2010","journal-title":"J Biol Chem"},{"key":"R9-19-20230208","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1681\/ASN.2005020142","article-title":"Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.","volume":"16","author":"Wada","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R10-19-20230208","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1681\/ASN.2013080902","article-title":"Tubular p53 regulates multiple genes to mediate AKI.","volume":"25","author":"Zhang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R11-19-20230208","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1046\/j.1523-1755.2003.00877.x","article-title":"Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood.","volume":"63","author":"Srivastava","year":"2003","journal-title":"Kidney Int"},{"key":"R12-19-20230208","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ajpath.2013.06.033","article-title":"New insights into the pathology of podocyte loss: mitotic catastrophe.","volume":"183","author":"Liapis","year":"2013","journal-title":"Am J Pathol"},{"key":"R13-19-20230208","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-linked Alport syndrome.","volume":"15","author":"Rheault","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R14-19-20230208","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","article-title":"Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease.","volume":"24","author":"Silverstein","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R15-19-20230208","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis.","volume":"7","author":"Liu","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R16-19-20230208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s100240050025","article-title":"Lysozyme immunostaining in renal tubular dysgenesis.","volume":"3","author":"Moldavsky","year":"2000","journal-title":"Pediatr Dev Pathol"},{"key":"R17-19-20230208","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0955-0674(95)80112-X","article-title":"Adhesion in cell migration.","volume":"7","author":"Huttenlocher","year":"1995","journal-title":"Curr Opin Cell Biol"},{"key":"R18-19-20230208","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/01.ASN.0000054887.42550.14","article-title":"Podocyte differentiation and glomerulogenesis.","volume":"14","author":"Kreidberg","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R19-19-20230208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2014.08.015","article-title":"Mechanisms of p53 degradation.","volume":"438","author":"Chao","year":"2015","journal-title":"Clin Chim Acta"},{"key":"R20-19-20230208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2440","article-title":"The Human Protein Atlas\u2014a tool for pathology.","volume":"216","author":"Pont\u00e9n","year":"2008","journal-title":"J Pathol"},{"key":"R22-19-20230208","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3892\/or.2014.3045","article-title":"CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.","volume":"31","author":"Li","year":"2014","journal-title":"Oncol Rep"},{"key":"R23-19-20230208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.humpath.2014.07.026","article-title":"PBK\/TOPK expression correlates with mutant p53 and affects patients\u2019 prognosis and cell proliferation and viability in lung adenocarcinoma.","volume":"46","author":"Lei","year":"2015","journal-title":"Hum Pathol"},{"key":"R24-19-20230208","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1477-7819-11-314","article-title":"Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast.","volume":"11","author":"Choi","year":"2013","journal-title":"World J Surg Oncol"},{"key":"R25-19-20230208","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.neo.2014.10.007","article-title":"KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells.","volume":"16","author":"Taniuchi","year":"2014","journal-title":"Neoplasia"},{"key":"R26-19-20230208","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/carcin\/bgu065","article-title":"Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression.","volume":"35","author":"Yu","year":"2014","journal-title":"Carcinogenesis"},{"key":"R27-19-20230208","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2407-9-196","article-title":"KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?","volume":"9","author":"Valensin","year":"2009","journal-title":"BMC Cancer"},{"key":"R28-19-20230208","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/carcin\/bgu327","article-title":"RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.","volume":"36","author":"Imaoka","year":"2015","journal-title":"Carcinogenesis"},{"key":"R29-19-20230208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","article-title":"Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.","volume":"356","author":"Donehower","year":"1992","journal-title":"Nature"},{"key":"R30-19-20230208","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: the cell\u2019s response to p53.","volume":"2","author":"Vousden","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R31-19-20230208","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1158\/0008-5472.CAN-04-3589","article-title":"Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation.","volume":"65","author":"Hodge","year":"2005","journal-title":"Cancer Res"},{"key":"R32-19-20230208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11010-010-0514-6","article-title":"Anoikis triggers Mdm2-dependent p53 degradation.","volume":"343","author":"Ghosh","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"R33-19-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2014.01.009","article-title":"Mdm2 is required for maintenance of the nephrogenic niche.","volume":"387","author":"Hilliard","year":"2014","journal-title":"Dev Biol"},{"key":"R34-19-20230208","doi-asserted-by":"crossref","first-page":"F928","DOI":"10.1152\/ajprenal.00642.2011","article-title":"Mechanisms of p53 activation and physiological relevance in the developing kidney.","volume":"302","author":"Aboudehen","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R35-19-20230208","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1947601911409747","article-title":"Inflammation and p53: A Tale of Two Stresses.","volume":"2","author":"Gudkov","year":"2011","journal-title":"Genes Cancer"},{"key":"R36-19-20230208","doi-asserted-by":"crossref","first-page":"e99083","DOI":"10.1371\/journal.pone.0099083","article-title":"Laminin \u03b12-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.","volume":"9","author":"Delimont","year":"2014","journal-title":"PLoS ONE"},{"key":"R37-19-20230208","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2174\/187152011796817619","article-title":"FAK and p53 protein interactions.","volume":"11","author":"Golubovskaya","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"R38-19-20230208","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1158\/0008-5472.CAN-04-2908","article-title":"Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis.","volume":"65","author":"Meyer","year":"2005","journal-title":"Cancer Res"},{"key":"R39-19-20230208","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI39569","article-title":"Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.","volume":"120","author":"Tanaka","year":"2010","journal-title":"J Clin Invest"},{"key":"R40-19-20230208","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nm0602-620","article-title":"CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.","volume":"8","author":"Linker","year":"2002","journal-title":"Nat Med"},{"key":"R41-19-20230208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1476-4598-13-206","article-title":"Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.","volume":"13","author":"Su","year":"2014","journal-title":"Mol Cancer"},{"key":"R42-19-20230208","doi-asserted-by":"crossref","first-page":"e25641","DOI":"10.1371\/journal.pone.0025641","article-title":"RSPO1\/\u03b2-catenin signaling pathway regulates oogonia differentiation and entry into meiosis in the mouse fetal ovary.","volume":"6","author":"Chassot","year":"2011","journal-title":"PLoS ONE"},{"key":"R43-19-20230208","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1681\/ASN.2012050469","article-title":"p53 is renoprotective after ischemic kidney injury by reducing inflammation.","volume":"24","author":"Sutton","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R44-19-20230208","doi-asserted-by":"crossref","first-page":"F284","DOI":"10.1152\/ajprenal.00317.2011","article-title":"The p53 inhibitor pifithrin-\u03b1 can stimulate fibrosis in a rat model of ischemic acute kidney injury.","volume":"302","author":"Dagher","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R45-19-20230208","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.","volume":"20","author":"Molitoris","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R46-19-20230208","doi-asserted-by":"crossref","first-page":"F1617","DOI":"10.1152\/ajprenal.00279.2013","article-title":"Silencing of p53 RNA through transarterial delivery ameliorates renal tubular injury and downregulates GSK-3\u03b2 expression after ischemia-reperfusion injury.","volume":"305","author":"Fujino","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R47-19-20230208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/excr.1997.3739","article-title":"Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.","volume":"236","author":"Mundel","year":"1997","journal-title":"Exp Cell Res"},{"key":"R48-19-20230208","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/gene.10164","article-title":"Podocyte-specific expression of Cre recombinase in transgenic mice.","volume":"35","author":"Moeller","year":"2003","journal-title":"Genesis"},{"key":"R49-19-20230208","first-page":"3313","article-title":"Enhanced proliferative potential in culture of cells from p53-deficient mice.","volume":"8","author":"Tsukada","year":"1993","journal-title":"Oncogene"},{"key":"R50-19-20230208","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","article-title":"A new method for large scale isolation of kidney glomeruli from mice.","volume":"161","author":"Takemoto","year":"2002","journal-title":"Am J Pathol"},{"key":"R51-19-20230208","doi-asserted-by":"crossref","first-page":"e43852","DOI":"10.1371\/journal.pone.0043852","article-title":"Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndrome.","volume":"7","author":"Koga","year":"2012","journal-title":"PLoS ONE"},{"key":"R52-19-20230208","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.2491","article-title":"Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.","volume":"17","author":"Boll\u00e9e","year":"2011","journal-title":"Nat Med"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201601000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:32Z","timestamp":1786130792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201601000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014111109","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}